Innatrix

Innatrix is an early stage agricultural biotechnology company with a mission to develop a biological platform for creating sustainable, eco-friendly biopesticides to combat currently untreatable crop diseases and pests. The company focuses on addressing significant crop loss caused by pathogens such as potato late blight, soybean cyst nematode, and citrus greening, which lead to an estimated 20-40% yield reduction, with over $100B spent annually to combat them. Innatrix's innovative approach involves creating biopesticides with highly specific protein ligands that target the pests or pathogens of interest. These biopesticides stand out not only for their specific targeting mechanisms but also for their ability to evolve into more effective products. This is made possible by Innatrix’s patented evolution platform, EvoStat, which modifies existing products to counter potential resistance from pests or pathogens. The company’s efforts align with the increasing demand for ecofriendly and sustainable solutions in agriculture. Innatrix was founded in 2013 and is headquartered in the United States. Their most recent investment was a Convertible Note investment on 10 March 2022. Innatrix presents an intriguing investment opportunity for venture capitalists seeking to support innovative solutions in the agricultural and biotechnology sectors, addressing critical challenges and contributing to sustainable food production.